AstraZeneca’s COVID-19 cocktail clears first step for registration in Australia -Breaking
[ad_1]
© Reuters. FILE PHOTO – Astra Zeneca Coronavirus Vaccine 19 Coronavirus Vaccine and Vials are seen together in this illustration taken on March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo(Reuters] – Australia’s regulatory body for medicine said Tuesday that it granted AstraZeneca provisional approval (NASDAQ:) to use its antigen cocktail as a protective measure against COVID-19.
Therapeutic Goods Administration announced that Anglo-Swedish pharmaceutical company is now eligible for provisional registration of the antibody cocktail, EVUSHELD in Australia.
Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]